Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena MT, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.

Front Immunol. 2017 Oct 10;8:1244. doi: 10.3389/fimmu.2017.01244. eCollection 2017.

2.

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.

Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017. Erratum in: Front Immunol. 2017 Oct 10;8:1244.

3.

Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.

Ghosh S, Nandi M, Pal S, Mukhopadhyay D, Chakraborty BC, Khatun M, Bhowmick D, Mondal RK, Das S, Das K, Ghosh R, Banerjee S, Santra A, Chatterjee M, Chowdhury A, Datta S.

Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.

4.

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56dim Natural Killer Cells.

Lajoie L, Congy-Jolivet N, Bolzec A, Thibault G.

Front Immunol. 2017 Nov 20;8:1556. doi: 10.3389/fimmu.2017.01556. eCollection 2017.

5.

Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.

Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardañons J, Comas DI, Di Giovanni D, Gaillard MI, Bezrodnik L, Zwirner NW.

PLoS One. 2012;7(12):e51677. doi: 10.1371/journal.pone.0051677. Epub 2012 Dec 11.

6.

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.

J Hepatol. 2009 Sep;51(3):458-67. doi: 10.1016/j.jhep.2009.05.030. Epub 2009 Jun 25.

7.

Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.

Caldirola MS, Rodríguez Broggi MG, Gaillard MI, Bezrodnik L, Zwirner NW.

Front Immunol. 2018 Jun 22;9:1429. doi: 10.3389/fimmu.2018.01429. eCollection 2018.

8.

Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.

Batoni G, Esin S, Favilli F, Pardini M, Bottai D, Maisetta G, Florio W, Campa M.

Scand J Immunol. 2005 Dec;62(6):498-506.

9.

Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.

Lima JF, Oliveira LM, Pereira NZ, Mitsunari GE, Duarte AJ, Sato MN.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):463-71. doi: 10.1097/QAI.0000000000000350.

PMID:
25230289
10.

Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.

Lehmann D, Spanholtz J, Osl M, Tordoir M, Lipnik K, Bilban M, Schlechta B, Dolstra H, Hofer E.

Stem Cells Dev. 2012 Nov 1;21(16):2926-38. doi: 10.1089/scd.2011.0659. Epub 2012 Jul 17.

11.

Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.

Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, Beagley K, Healy H, Kassianos AJ.

Kidney Int. 2017 Jul;92(1):79-88. doi: 10.1016/j.kint.2017.02.006. Epub 2017 Apr 8.

PMID:
28396119
12.

[Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].

Li ZS, Shao ZH, Fu R, Wang J, Li LJ, Zhang T, Wang HQ, Wu YH, Ruan EB, Song J, Qu W, Liu H, Xing LM, Wang XM, Liang Y, Guan J, Wang GJ.

Zhonghua Yi Xue Za Zhi. 2011 Apr 26;91(16):1084-7. Chinese.

PMID:
21609587
13.

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.

Nielsen N, Ødum N, Ursø B, Lanier LL, Spee P.

PLoS One. 2012;7(2):e31959. doi: 10.1371/journal.pone.0031959. Epub 2012 Feb 22.

14.

Progesterone-induced blocking factor inhibits degranulation of natural killer cells.

Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J.

Am J Reprod Immunol. 1999 Aug;42(2):71-5.

PMID:
10476687
15.

Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.

Miyagi T, Shimizu S, Tatsumi T, Nishio K, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

J Gastroenterol. 2011 Aug;46(8):1020-30. doi: 10.1007/s00535-011-0408-8. Epub 2011 May 11.

PMID:
21559771
16.

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, McQueen KL, Guethlein LA, Parham P, Miller JS.

Blood. 2007 Jul 15;110(2):578-86. Epub 2007 Mar 28.

17.

Circulating NK cells and their subsets in Behçet's disease.

Hasan MS, Ryan PL, Bergmeier LA, Fortune F.

Clin Exp Immunol. 2017 May;188(2):311-322. doi: 10.1111/cei.12939. Epub 2017 Mar 13.

18.

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA.

Blood. 2010 Jan 14;115(2):274-81. doi: 10.1182/blood-2009-04-215491. Epub 2009 Nov 6.

19.

Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56-CD16+ Natural Killer Cell Subset Is Associated with Natural Killer Cell Dysfunction in Chronic HIV-1 Clade C Infection.

Zulu MZ, Naidoo KK, Mncube Z, Jaggernath M, Goulder PJR, Ndung'u T, Altfeld M, Thobakgale CF.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1205-1213. doi: 10.1089/AID.2017.0095. Epub 2017 Sep 21.

PMID:
28810810
20.

Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Amand M, Iserentant G, Poli A, Sleiman M, Fievez V, Sanchez IP, Sauvageot N, Michel T, Aouali N, Janji B, Trujillo-Vargas CM, Seguin-Devaux C, Zimmer J.

Front Immunol. 2017 Jun 19;8:699. doi: 10.3389/fimmu.2017.00699. eCollection 2017.

Supplemental Content

Support Center